Semler Scientific, Inc. (SMLR)

Market Cap	415.86M
Revenue (ttm)	42.98M
Net Income (ttm)	37.05M
Shares Out	14.80M
EPS (ttm)	3.94
PE Ratio	7.13
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	567,678
Open	29.09
Previous Close	29.01
Day's Range	27.55 - 29.27
52-Week Range	21.77 - 81.56
Beta	1.40
Analysts	Strong Buy
Price Target	81.75 (+191.03%)
Earnings Date	Nov 3, 2025

About SMLR

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. The company’s products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, ind...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 21, 2014
• Employees: 79
• Stock Exchange: NASDAQ
• Ticker Symbol: SMLR
• Website: https://www.semlerscientific.com

Financial Performance

In 2024, Semler Scientific's revenue was $56.29 million, a decrease of -17.44% compared to the previous year's $68.18 million. Earnings were $40.90 million, an increase of 98.70%.

Analyst Summary

According to 4 analysts, the average rating for SMLR stock is "Strong Buy." The 12-month stock price target is $81.75, which is an increase of 191.03% from the latest price.

Price Target

$81.75

(191.03% upside)

Analyst Consensus: Strong Buy